Gerald Phd Mcmahon, Director at Oncotelic Therapeutics, holds 172.46K shares in Harpoon Therapeutics (Ticker: HARP), holds 180.70K shares in Celldex (Ticker: CLDX), holds 18.61K shares in Oncotelic Therapeutics (Ticker: OTLC). Most recently, Gerald Phd Mcmahon Bought ― shares of Harpoon Therapeutics on May 16, 2019 for an estimated value of 10.15K.
Gerald Phd Mcmahon latest transaction was an Informative Buy of $10.15K.
What was Gerald Phd Mcmahon's most profitable transaction?
Gerald Phd Mcmahon’s most profitable transaction was an Informative Buy of HARP stock on May 16, 2019. The return on the trade was 35.40%.
What is Gerald Phd Mcmahon's role in Oncotelic Therapeutics?
Gerald Phd Mcmahon's role in Oncotelic Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.